US 11903922
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted A61KA61K31/352A61K31/366
Quick answer
US patent 11903922 (Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders) held by Amazentis SA expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Amazentis SA
- Grant date
- Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/352, A61K31/366, A61K31/7048, A61K36/185